Key result
Platycodin D dose-dependently alleviates cisplatin-induced oxidative stress, apoptosis, and inflammation in HEK-293 cells.
Why the study?
Cisplatin is clinically effective for malignant solid tumors but limited by nephrotoxicity, prompting investigation into whether Platycodin D protects against cisplatin-induced kidney cell injury.
Does Platycodin D prevent cisplatin-induced cytotoxicity in HEK-293 cells?
Does Platycodin D prevent cisplatin-induced cytotoxicity in HEK-293 cells?
Platycodin D protects against cisplatin-induced cytotoxicity in HEK-293 cells by suppressing oxidative stress, apoptosis, and inflammation, suggesting potential for attenuating cisplatin-induced nephrotoxicity.
Answers are grounded in this paper and cite their sources.
In vitro PD protection against cisplatin HEK-293 injury; hypothesis-generating and requires in vivo validation before any clinical consideration.
Cisplatin, a proven effective chemotherapeutic agent, has been used clinically to treat malignant solid tumors, whereas its clinical use is limited by serious side effect including nephrotoxicity. Platycodin D (PD), the major and marked saponin isolated from Platycodon grandiflorum, possesses many pharmacological effects. In this study, we evaluated its protective effect against cisplatin-induced human embryonic kidney 293 (HEK-293) cells injury and elucidated the related mechanisms. Our results showed that PD (0.25, 0.5, and 1 μM) can dose-dependently alleviate oxidative stress by decreasing malondialdehyde and reactive oxygen species, while increasing the levels of glutathione, superoxide dismutase, and catalase. Moreover, the elevation of apoptosis including Bax, Bad, cleaved caspase-3,-9, and decreased protein levels of Bcl-2, Bcl-XL induced by cisplatin were reversed after PD treatment. Importantly, PD pretreatment can also regulate PI3K/Akt and ERK/JNK/p38 signaling pathways. Furthermore, PD was found to reduce NF-κB-mediated inflammatory relative proteins. Our finding indicated that PD exerted significant effects on cisplatin induced oxidative stress, apoptosis and inflammatory, which will provide evidence for the development of PD to attenuate cisplatin-induced nephrotoxicity.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2020) studied Cisplatin-induced cytotoxicity. Platycodin D vs. Cisplatin alone was evaluated on Oxidative stress, apoptosis, and inflammation markers. Platycodin D dose-dependently alleviated cisplatin-induced oxidative stress, apoptosis, and inflammation in HEK-293 cells.
Synapse has enriched 10 related papers. Consider them for comparative context: